Bernard Huber
Impact in
- Genetics top 10%
- Virus-based gene therapy research
-
- CAR-T cell therapy research
Papers in
- Co-authors
- Ottheinz Krebs (5 shared papers)Jean Rommelaere (5 shared papers)Karsten Geletneky (5 shared papers)Jacek Hajda (5 shared papers)Michael Dahm (5 shared papers)Barbara Leuchs (4 shared papers)Magnus von Knebel Doeberitz (1 shared paper)Johannes Huesing (2 shared papers)
- Journals
- BMC Cancer (2 papers)Journal of Clinical Oncology (1 paper)PubMed (2 papers)
In The Last Decade
Bernard Huber
5 papers receiving 196 citations
Peers
Comparison fields: 5 of 31
- Genetics 162
- Oncology 120
- Infectious Diseases 52
- Biotechnology 22
- Animal Science and Zoology 21
Countries citing papers authored by Bernard Huber
This map shows the geographic impact of Bernard Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Huber more than expected).
Fields of papers citing papers by Bernard Huber
This network shows the impact of papers produced by Bernard Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Huber. The network helps show where Bernard Huber may publish in the future.
Co-authors
The 22 scholars most cited alongside Bernard Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 132 | |
| 2 | 2017 | 40 | |
| 3 | Bioavailability, biodistribution, and CNS toxicity of clinical-grade parvovirus H1 after intravenous and intracerebral injection in rats. | 2015 | 14 |
| 4 | Pathology, organ distribution, and immune response after single and repeated intravenous injection of rats with clinical-grade parvovirus H1. | 2015 | 13 |
| 5 | 2014 | 1 |
About Bernard Huber
Bernard Huber is a scholar working on Genetics, Oncology, Biotechnology, Infectious Diseases and Molecular Biology, having authored 5 papers that have together received 200 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), CAR-T cell therapy research (2 papers), Cancer Research and Treatments (2 papers), Parvovirus B19 Infection Studies (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Genetics (162 citations), Oncology (120 citations), Infectious Diseases (52 citations), Biotechnology (22 citations) and Animal Science and Zoology (21 citations). Bernard Huber has collaborated with scholars based in Germany, Norway and France. Frequent co-authors include Ottheinz Krebs, Jean Rommelaere, Karsten Geletneky, Jacek Hajda, Michael Dahm, Barbara Leuchs, Magnus von Knebel Doeberitz, Johannes Huesing, Niels Halama and Dirk Jäger. Their work appears in journals such as BMC Cancer, Journal of Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.